Cyrus Harmon
Förmögenhet: 11 M $ per 2026-05-31
Förmögenhet: 11 M $ per 2026-05-31
Cyrus L.
Harmon was the founder of Neomorphics, Inc., founded in 1996, where the title held was Chief Executive Officer from 1996 to 2000.
Dr. Harmon is the founder of Olema Pharmaceuticals, Inc., founded in 2006, holding the title of Independent Director.
Dr. Harmon currently works at Vilya, Inc. as President & Chief Executive Officer since 2023.
Formerly, Dr. Harmon was General Manager at Affymetrix, Inc. from 2000 to 2002.
Education includes undergraduate and doctorate degrees from the University of California, Berkeley.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-18 | 844 798 ( 0,97 % ) | 11 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Grundare | 2006-08-07 |
Vilya Inc.
Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Verkställande Direktör | 2023-10-01 |
| Företag | Position | Slut |
|---|---|---|
| AFFYMETRIX, INC. | Företagsledare/Principal | 2002-01-01 |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Verkställande Direktör | 2000-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Affymetrix, Inc.
Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Vilya Inc.
Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån